- Home
- WTW vs DXCM Comparison
WTW vs DXCM Comparison
Compare WTW & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTW
- DXCM
- Stock Information
- Founded
- WTW 1828
- DXCM 1999
- Country
- WTW United Kingdom
- DXCM United States
- Employees
- WTW N/A
- DXCM N/A
- Industry
- WTW Specialty Insurers
- DXCM Medical/Dental Instruments
- Sector
- WTW Finance
- DXCM Health Care
- Exchange
- WTW Nasdaq
- DXCM Nasdaq
- Market Cap
- WTW 32.8B
- DXCM 31.7B
- IPO Year
- WTW N/A
- DXCM 2005
- Fundamental
- Price
- WTW $321.95
- DXCM $58.50
- Analyst Decision
- WTW Buy
- DXCM Strong Buy
- Analyst Count
- WTW 12
- DXCM 20
- Target Price
- WTW $369.92
- DXCM $88.20
- AVG Volume (30 Days)
- WTW 718.1K
- DXCM 8.3M
- Earning Date
- WTW 10-30-2025
- DXCM 10-30-2025
- Dividend Yield
- WTW 1.14%
- DXCM N/A
- EPS Growth
- WTW N/A
- DXCM 7.75
- EPS
- WTW 21.32
- DXCM 1.80
- Revenue
- WTW $9,807,000,000.00
- DXCM $4,515,900,000.00
- Revenue This Year
- WTW N/A
- DXCM $17.43
- Revenue Next Year
- WTW $6.11
- DXCM $13.22
- P/E Ratio
- WTW $15.11
- DXCM $32.31
- Revenue Growth
- WTW N/A
- DXCM 14.21
- 52 Week Low
- WTW $292.97
- DXCM $54.11
- 52 Week High
- WTW $352.79
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- WTW 45.53
- DXCM 37.96
- Support Level
- WTW $317.90
- DXCM $54.11
- Resistance Level
- WTW $328.67
- DXCM $60.85
- Average True Range (ATR)
- WTW 6.36
- DXCM 2.60
- MACD
- WTW 0.60
- DXCM -0.21
- Stochastic Oscillator
- WTW 70.89
- DXCM 25.99
About WTW Willis Towers Watson Public Limited Company
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.